Please login to the form below

Not currently logged in
Email:
Password:

EMA recruits patient voices for its management board

Continues its drive to embed patients' values within drug assessment

EMAThe European Medicine Agency (EMA) has appointed two new patient organisation representatives to its management board.

Ilaria Passarani and Yann Le Cam will be responsible for ensuring the views and needs of patients are taken into account over the next three years.

Passarani currently serves as head of the food and health department at the European Consumer Organisation (BEUC), while Le Cam is chief executive and co-founder of the European Organisation for Rare Diseases (Eurordis).

Also joining the EMA's board is Tonio Borg, who will represent the European Parliament alongside Björn Lemmer who has been reappointed to this role.

Borg is a former European commissioner for health, while Lemmer was a member of the National Commission on Prescription of Drugs in Germany.

Meanwhile, representing healthcare professionals' organisations, Wolf-Dieter Ludwig has been re-appointed to the management board. Ludwig leads the haematology, oncology, tumor immunology and palliative care department at Helios Klinikum Berlin-Buch, a hospital in Germany.

In 2014 the EMA piloted a scheme to involve patients in the assessment of the benefits and risks of medicines in its scientific advisory committee.

The project invited patients to present their views on medicines under deliberation by the agency for which there was an unmet medical need and no clear decision by the regulatory committee.

While patients did not take part in any actual decision-making, the pilot brought a day-to-day understanding of the impact on quality of life that these medicines offered - an alternative viewpoint to those of other stakeholders.

Article by
Rebecca Clifford

17th June 2016

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics